Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cancers
|
December 7, 2018
Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
Ya Gao, Wies R Vallentgoed, Pim J French
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2022
Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review
C Mircea S Tesileanu, Wies R Vallentgoed, Pim J French, et al.
Iscience
|
January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data
Levi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Nature Communications
|
January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma
Levi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Acta Neuropathologica
|
October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Neuro-Oncology Advances
|
November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
Karin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Cell Reports. Medicine
|
March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas
Youri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Nature Cancer
|
August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Acta Neuropathologica
|
March 19, 2021
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
C Mircea S Tesileanu, Wies R Vallentgoed, Marc Sanson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cancers
|
December 7, 2018
Finding the Right Way to Target EGFR in Glioblastomas; Lessons from Lung Adenocarcinomas
Ya Gao, Wies R Vallentgoed, Pim J French
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2022
Molecular markers related to patient outcome in patients with IDH-mutant astrocytomas grade 2 to 4: A systematic review
C Mircea S Tesileanu, Wies R Vallentgoed, Pim J French, et al.
Iscience
|
January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data
Levi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Nature Communications
|
January 29, 2025
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma
Levi van Hijfte, Marjolein Geurts, Iris de Heer, et al.
Acta Neuropathologica
|
October 9, 2024
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, et al.
Neuro-Oncology Advances
|
November 29, 2023
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
Karin A van Garderen, Wies R Vallentgoed, Anna Lavrova, et al.
Cell Reports. Medicine
|
March 18, 2026
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas
Youri Hoogstrate, Santoesha A Ghisai, Levi van Hijfte, et al.
Nature Cancer
|
August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Acta Neuropathologica
|
March 19, 2021
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
C Mircea S Tesileanu, Wies R Vallentgoed, Marc Sanson, et al.
Page
of 2